An Observational Study Evaluating the Utility of Ultrasound Confirmed Enthesitis as a Prognostic Marker for Response to Biologic Therapy in Psoriatic Arthritis
Latest Information Update: 09 Feb 2022
At a glance
- Drugs Adalimumab (Primary) ; Certolizumab pegol (Primary) ; Etanercept (Primary) ; Golimumab (Primary) ; Secukinumab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
Most Recent Events
- 03 Feb 2022 Status changed from recruiting to completed.
- 22 May 2019 New trial record